Akèy › Kansè poumon selil ti › Michigan › Detroit
Etid klinik pou Kansè poumon selil ti nan Detroit, MI
12 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote Detroit (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Ap rekriteFaz 2
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Ap rekriteFaz 1/2
- Barbara Ann Karmanos Cancer Center, Detroit
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Karmanos Cancer Institute, Detroit
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Ap rekriteFaz 3
- Henry Ford Health Cancer, Detroit
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Ap rekriteFaz 1
- Henry Ford Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Karmanos Cancer Institute, Detroit
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Ap rekriteFaz 3
- Henry Ford Health System, Detroit
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Ap rekriteFaz 2
- Henry Ford Cancer- Detroit, Detroit
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
Ap rekriteFaz 2
- Karmanos Cancer Center (Wayne State University), Detroit
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Ap rekriteFaz 2
- Henry Ford Health Saint John Hospital, Detroit
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Henry Ford Health System, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 129, Detroit
Etid Kansè poumon selil ti nan lòt vil
- Houston, TX26 etid
- Arlington, VA23 etid
- New York City, NY22 etid
- Boston, MA21 etid
- Los Angeles, CA20 etid
- Nashville, TN20 etid
- Orlando, FL15 etid
- Dallas, TX13 etid
- Cleveland, OH13 etid
- Chicago, IL13 etid
- St. Louis, MO13 etid
- Washington, DC12 etid
Lòt etid nan Detroit
- Kansè Poumon ki pa ti selil44 etid
- Kansè nan tete33 etid
- Kansè (tout kalite)29 etid
- Kansè kolorektal26 etid
- Kansè ovè26 etid
- Kansè Metastatik24 etid
- Kansè pwostat22 etid
- Kansè Endomèt21 etid
- Kansè poumon20 etid
- Myelom Miltip19 etid
- Kansè lestomak16 etid
- Karsinòm selil skuamèz tèt ak kou15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.